# Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

> **NCT00633282** · PHASE2 · COMPLETED · sponsor: **Xin Gao** · enrollment: 184 (actual)

## Conditions studied

- Nonalcoholic Fatty Liver Disease

## Interventions

- **BEHAVIORAL:** Life style intervention
- **DRUG:** pioglitazone
- **DRUG:** berberine

## Key facts

- **NCT ID:** NCT00633282
- **Lead sponsor:** Xin Gao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633282, "Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00633282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*